Efavirenz
Drug Details
- Generic Name
- Efavirenz
- Brand Names
- Efavirenz
- Application Number
- ANDA077673
- Sponsor
- Siegfried St. Vulbas SAS
- NDC Codes
- 21
- Dosage Forms
- POWDER, CAPSULE, TABLET, FILM COATED, TABLET
- Routes
- ORAL
- Active Ingredients
- EFAVIRENZ
Indications and Usage
1 INDICATIONS AND USAGE Efavirenz, Emtricitabine and Tenofovir disoproxil fumarate tablet is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablet is a three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. ( 1 )